WHO Okays Injection To Prevent HIV, Nigeria May Benefit
*N60,000, Every Six Months *Bill Clinton, WHO Speak On New Drug *Countries With Rising Infection Rates Won't Benefit Cheap supplies of a groundbreaking twice-yearly HIV prevention jab will be available in many poorer countries within two years, funders have promised. The drug, Lenacapavir, will cost $40 (about N60,000) a patient a year in 120 low- and middle-income countries (LMICs) from 2027, under two agreements with generic drug manufacturers announced this week. Last year there were 1.3m new HIV infections globally and experts have said that Lenacapavir, as a preventive drug or “pre-exposure prophylaxis” (PrEP), could have a transformative effect on…












